Skip to content

Comprehensive efficacy evaluation of exposure therapy and aversion therapy based on virtual reality technology for patients with alcohol dependence

Comprehensive efficacy evaluation of exposure therapy and aversion therapy based on virtual reality technology for patients with alcohol dependence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110026
Enrollment
Unknown
Registered
2025-09-29
Start date
2024-09-22
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol dependence

Interventions

Ccontrol group:The control group received routine clinical treatment and watched the above VR relaxation scene. At the initial stage of admission, the patients were mainly given benzodiazepine replace
VR-AT group:The vr-at group received conventional clinical treatment and VR aversion treatment for 15 days, a total of 8 times, with an interval of 1 day, each time for about 10min. During the first a
VR-CET group:On the basis of conventional clinical treatment, VR-CET group was treated with VR-CET for 15 days, a total of 8 times, with an interval of 1 day, and each time was about 10 minutes. The p

Sponsors

The Second Affiliated Hospital of Xinxiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.It met the diagnostic criteria of "alcohol dependence" in ICD-10; 2.Male, aged 18-60 years; 3.Primary school education or above; 4.There was no obvious physical withdrawal symptoms (clinical alcohol withdrawal status assessment scale score<7); 5.Be able to cooperate with VR treatment, agree to complete the follow-up evaluation, and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Have a history of serious physical disease or brain organic disease; 2.Have a history of substance abuse other than alcohol and nicotine; 3.Have a history of other mental diseases; 4.Visual problems that hinder viewing virtual reality environment.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale Score;Penn Alcohol Craving Scale Score;Hamilton Anxiety Scale score;Depression symptom level (Hamilton Depression Rating Scale score);Pittsburgh Sleep Quality Index score;Rehydration;Eye movement data;Grab data;

Secondary

MeasureTime frame
Clinical Alcohol Withdrawal Scale Rating;

Countries

China

Contacts

Public ContactZhao Haoyu

The Second Affiliated Hospital of Xinxiang Medical University

870947891@qq.com+86 155 3903 6675

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026